S243: ANTIBODY AND T-CELL RESPONSE SIX MONTHS AFTER INITIATION OF BNT162B2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA OR CHRONIC LYMPHATIC B-CELL LEUKEMIA COMPARED TO HEALTHY CONTROLS
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843864.94970.a3 |
| _version_ | 1827336859376680960 |
|---|---|
| author | L. D. Heftdal L. Pérez-Alós S. R. Ham J. R. Madsen K. Fogh C. C. Kronborg A. P. Vallentin R. B. Hasselbalch S. R. Ostrowski R. Frikke-Schmidt E. Sørensen L. Hilsted H. Bundgaard K. Iversen P. Garred S. D. Nielsen K. Grønbæk |
| author_facet | L. D. Heftdal L. Pérez-Alós S. R. Ham J. R. Madsen K. Fogh C. C. Kronborg A. P. Vallentin R. B. Hasselbalch S. R. Ostrowski R. Frikke-Schmidt E. Sørensen L. Hilsted H. Bundgaard K. Iversen P. Garred S. D. Nielsen K. Grønbæk |
| author_sort | L. D. Heftdal |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:39Z |
| format | Article |
| id | doaj.art-8201d961b75e4e52a85d8b0b1f14387d |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:39Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-8201d961b75e4e52a85d8b0b1f14387d2024-03-02T03:51:53ZengWileyHemaSphere2572-92412022-06-01614414510.1097/01.HS9.0000843864.94970.a3202206003-00144S243: ANTIBODY AND T-CELL RESPONSE SIX MONTHS AFTER INITIATION OF BNT162B2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA OR CHRONIC LYMPHATIC B-CELL LEUKEMIA COMPARED TO HEALTHY CONTROLSL. D. Heftdal0L. Pérez-Alós1S. R. Ham2J. R. Madsen3K. Fogh4C. C. Kronborg5A. P. Vallentin6R. B. Hasselbalch7S. R. Ostrowski8R. Frikke-Schmidt9E. Sørensen10L. Hilsted11H. Bundgaard12K. Iversen13P. Garred14S. D. Nielsen15K. Grønbæk161 Department of Hematology4 Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631,, Rigshospitalet, Copenhagen University Hospital, Copenhagen2 Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital4 Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631,, Rigshospitalet, Copenhagen University Hospital, Copenhagen5 Department of Cardiology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev2 Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital1 Department of Hematology5 Department of Cardiology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev6 Department of Clinical Immunology, Section 2034, Rigshospitalet, Copenhagen University Hospital7 Department of Clinical Medicine, University of Copenhagen6 Department of Clinical Immunology, Section 2034, Rigshospitalet, Copenhagen University Hospital8 Department of Clinical Biochemistry7 Department of Clinical Medicine, University of Copenhagen5 Department of Cardiology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev4 Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631,, Rigshospitalet, Copenhagen University Hospital, Copenhagen2 Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital1 Department of Hematologyhttp://journals.lww.com/10.1097/01.HS9.0000843864.94970.a3 |
| spellingShingle | L. D. Heftdal L. Pérez-Alós S. R. Ham J. R. Madsen K. Fogh C. C. Kronborg A. P. Vallentin R. B. Hasselbalch S. R. Ostrowski R. Frikke-Schmidt E. Sørensen L. Hilsted H. Bundgaard K. Iversen P. Garred S. D. Nielsen K. Grønbæk S243: ANTIBODY AND T-CELL RESPONSE SIX MONTHS AFTER INITIATION OF BNT162B2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA OR CHRONIC LYMPHATIC B-CELL LEUKEMIA COMPARED TO HEALTHY CONTROLS HemaSphere |
| title | S243: ANTIBODY AND T-CELL RESPONSE SIX MONTHS AFTER INITIATION OF BNT162B2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA OR CHRONIC LYMPHATIC B-CELL LEUKEMIA COMPARED TO HEALTHY CONTROLS |
| title_full | S243: ANTIBODY AND T-CELL RESPONSE SIX MONTHS AFTER INITIATION OF BNT162B2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA OR CHRONIC LYMPHATIC B-CELL LEUKEMIA COMPARED TO HEALTHY CONTROLS |
| title_fullStr | S243: ANTIBODY AND T-CELL RESPONSE SIX MONTHS AFTER INITIATION OF BNT162B2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA OR CHRONIC LYMPHATIC B-CELL LEUKEMIA COMPARED TO HEALTHY CONTROLS |
| title_full_unstemmed | S243: ANTIBODY AND T-CELL RESPONSE SIX MONTHS AFTER INITIATION OF BNT162B2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA OR CHRONIC LYMPHATIC B-CELL LEUKEMIA COMPARED TO HEALTHY CONTROLS |
| title_short | S243: ANTIBODY AND T-CELL RESPONSE SIX MONTHS AFTER INITIATION OF BNT162B2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA OR CHRONIC LYMPHATIC B-CELL LEUKEMIA COMPARED TO HEALTHY CONTROLS |
| title_sort | s243 antibody and t cell response six months after initiation of bnt162b2 vaccination in patients with multiple myeloma or chronic lymphatic b cell leukemia compared to healthy controls |
| url | http://journals.lww.com/10.1097/01.HS9.0000843864.94970.a3 |
| work_keys_str_mv | AT ldheftdal s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT lperezalos s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT srham s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT jrmadsen s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT kfogh s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT cckronborg s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT apvallentin s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT rbhasselbalch s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT srostrowski s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT rfrikkeschmidt s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT esørensen s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT lhilsted s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT hbundgaard s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT kiversen s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT pgarred s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT sdnielsen s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols AT kgrønbæk s243antibodyandtcellresponsesixmonthsafterinitiationofbnt162b2vaccinationinpatientswithmultiplemyelomaorchroniclymphaticbcellleukemiacomparedtohealthycontrols |